HIV and Women: PrEP Coverage
PrEP (pre-exposure prophylaxis) coverage is one of the six Ending the HIV Epidemic in the U.S. indicators. PrEP coverage refers to the estimated percentage of people with indications for PrEP classified as having been prescribed PrEP.
PrEP Coverage Among Women in the US, 2019*†
* Based on sex assigned at birth.
† Among people aged 16 and older.
Source: CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2019. HIV Surveillance Supplemental Report 2021;26(2).
- CDC. Behavioral and clinical characteristics of persons with diagnosed HIV infection—Medical Monitoring Project, United States, 2020 cycle (June 2020–May 2021). HIV Surveillance Special Report 2022;29.
- CDC. Diagnoses of HIV infection in the United States and dependent areas, 2019. HIV Surveillance Report 2021;32.
- CDC. Estimated HIV incidence and prevalence in the United States, 2015-2019 [PDF – 3 MB]. HIV Surveillance Supplemental Report 2021;26(1).
- CDC. HIV infection risk, prevention, and testing behaviors among heterosexually active adults at increased risk for HIV infection–National HIV Behavioral Surveillance – 23 U.S. Cities, 2019 [PDF – 3 MB]. HIV Surveillance Special Report 2021; 26.
- CDC. HIV infection risk, prevention, and testing behaviors among persons who inject drugs–National HIV Behavioral Surveillance: injection drug use – 23 U.S. Cities, 2018 [PDF – 2 MB]. HIV Surveillance Special Report 2020; 24.
- CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2019. HIV Surveillance Supplemental Report 2021;26(2).
